HOMOLOGOUS RECOMBINATION DEFICIENCY
Clinical trials for HOMOLOGOUS RECOMBINATION DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HOMOLOGOUS RECOMBINATION DEFICIENCY trials appear
Sign up with your email to follow new studies for HOMOLOGOUS RECOMBINATION DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Withdrawn trial sought answers on race and cancer drug response
Disease control TerminatedThis study aimed to see if a standard drug combination for advanced prostate cancer works differently for men of different racial and ethnic backgrounds. It planned to enroll men who identified as Black, Hispanic, White, or Native American. The trial was withdrawn before any part…
Matched conditions: HOMOLOGOUS RECOMBINATION DEFICIENCY
Phase: PHASE2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists hunt for hidden weakness in lung cancer
Knowledge-focused OngoingThis study aims to understand how common a specific DNA repair problem is in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will look at tissue samples from 100 patients to see if having this problem is linked to how patients fare and if it m…
Matched conditions: HOMOLOGOUS RECOMBINATION DEFICIENCY
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC